Device / Technology News

RSS

Project aims to find new diagnostic tools, drugs for triple negative breast cancer

Some types of breast cancer can be successfully treated with drugs such as tamoxifen, but treatment for a type of breast cancer more common in young and black women is still limited to radiation and general chemotherapy. Called triple negative breast cancer, this type of cancer is the focus of a 20-month, $8.6-million research project that aims to find new diagnostic tools and options for drugs.

17 May 2012

Dako, VARI partner to license, manufacture and distribute cancer diagnostics

Van Andel Research Institute (VARI) and Dako, the Danish-based, worldwide supplier of cancer diagnostic tools today announce an agreement to license, manufacture and distribute cancer diagnostics utilizing the MET4 Antibody.

17 May 2012

SRI Sarnoff receives Lenel factory certification for IOM N-Glance identification system

SRI Sarnoff's Iris on the Move N-Glance identification system has received Lenel factory certification for its interface to Lenel's OnGuard software system.

17 May 2012

CAP, SoftTech Health announce partnership

SoftTech Health LLC of New York announces a partnership with the College of American Pathologists (CAP) to bring state-of-the-art accreditation management tools to clinical laboratories worldwide. Laboratory test results are said to drive the majority of all patient care decision-making, meaning that rigorous quality management (QM) of laboratory services is essential to safe and timely patient care.

17 May 2012

Pfizer outlines vision for Systems-based Pharmaceutics

Leading pharmaceuticals company Pfizer outlined its vision for Systems-based Pharmaceutics, a revolutionary model-based approach linking drug process and product engineering to product quality and performance in the human body, at the recent Advanced Process Modelling Forum in London.

17 May 2012

NanoString commences second clinical study of PAM50-based breast cancer assay

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay.

From NanoString Technologies 17 May 2012

NeuroSigma Subsidiary sees potential for Thin-Film Nitinol in next-generation flow-diverting stents for treating intracranial aneurysms

NeuroSigma, Inc., a Los Angeles-based medical device company, today announced that its majority-owned subsidiary, NSVascular, Inc. (NSV), acquired a portfolio of patents and related trade secrets covering the fabrication of Thin-Film Nitinol (TFN) from TiNi Alloy Company, including U.S. Patent No. 6,746,890 entitled “Three Dimensional Thin Film Devices and Methods of Fabrication,” an important piece of the portfolio covering the production of three-dimensional TFN constructs.

16 May 2012

Hitting the target: IntelliCap provides reliable and accurate regional drug delivery

Medimetrics, recently certified to ISO 13485, has successfully developed the IntelliCap system, specifically designed to target delivery of small molecule drugs and biologics to the gastrointestinal (GI) tract. The technology is capable of achieving controlled release of drugs to specific GI sites in a fast, cost-effective and convenient manner (Shimizu et al., 2008).

16 May 2012

Social networks influence beliefs regarding safety of influenza vaccines

College students' social networks influence their beliefs regarding the safety of influenza vaccines and decisions about vaccination, according to a new study in the Journal of Adolescent Health.

16 May 2012

Better understanding of new T-size descriptors on adjuvant chemotherapy effect needed

The most recent research released in June's Journal of Thoracic Oncology indicates there might be a positive correlation between tumor size and adjuvant platinum based chemotherapy in surgically resected patients with node negative non-small cell lung cancer.

16 May 2012

Colonic tissue may help predict Parkinson's disease

Two studies by neurological researchers at Rush University Medical Center suggest that, in the future, colonic tissue obtained during either colonoscopy or flexible sigmoidoscopy may be used to predict who will develop Parkinson's disease, a neurodegenerative disorder of aging that that leads to progressive deterioration of motor function due to loss of neurons in the brain that produce dopamine, a neurotransmitter essential to executing movement.

16 May 2012

Ultrasensitive biosensor may open up new opportunities for early detection of cancer

Researchers have created an ultrasensitive biosensor that could open up new opportunities for early detection of cancer and "personalized medicine" tailored to the specific biochemistry of individual patients.

16 May 2012

Mayo Clinic creates comprehensive mobile health application

Mayo Clinic has created a comprehensive mobile health application; combining a custom mobile experience with unparalleled expertise and access. Empowering patients with information at their fingertips, this app sets a new standard for health care apps.

16 May 2012

VATS plays a valuable role in lung cancer screening program

The most recent research released in June's Journal of Thoracic Oncology says video assisted thoracic surgery (VATS) is a valuable tool in managing lesions detected in a lung cancer screening program.

16 May 2012

Comcast, UnitedHealth Group completes enrollment in VOD study for type 2 diabetes

UnitedHealth Group and Comcast Corporation announced they have met enrollment targets for an innovative pilot study to evaluate the effectiveness of using video on demand (VOD) to deliver the Diabetes Prevention Program.

16 May 2012

Sorin receives PMDA authorization to market MEMO 3D ring

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announces that it received authorization from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) to market its MEMO 3D Semi-Rigid Annuloplasty Ring.

16 May 2012

Biomarker test can accurately detect early arthritis symptoms

More than 27 million adults currently suffer from osteoarthritis, which is the most common form of arthritis. In the past, doctors have been unable to diagnose patients with arthritis until they begin to show symptoms, which include joint pain and stiffness. By the time these symptoms are present, it is often too late for preventive and minimally invasive treatment options to be effective. Now, a research team from the University of Missouri's Comparative Orthopaedic Laboratory has found a way to detect and predict arthritis before patients begin suffering from symptoms.

16 May 2012

Avita commences enrollment in ReCell study for hypertrophic dyspigmented scars

Avita Medical Ltd.,the regenerative medicine company, today announced that it has commenced enrolment in the US FDA-approved feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars.

16 May 2012

HyperBranch’s Adherus AutoSpray Dural Sealant receives CE Marking

HyperBranch Medical Technology, Inc. announced today that it has received CE Marking for Adherus AutoSpray Dural Sealant.

16 May 2012

Thermo Fisher signs asset purchase agreement with Nephromics for PlGF assay

Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed an asset purchase agreement with Nephromics LLC, which includes a patent license for exclusive rights to use PlGF for the diagnosis of pre-eclampsia or eclampsia. Clinical trials have shown that PlGF supports the diagnosis and risk prediction for preeclampsia.

From Thermo Fisher Scientific Inc. 16 May 2012

Device / Technology News

Project aims to find new diagnostic tools, drugs for triple negative breast cancer

Dako, VARI partner to license, manufacture and distribute cancer diagnostics

SRI Sarnoff receives Lenel factory certification for IOM N-Glance identification system

CAP, SoftTech Health announce partnership

Pfizer outlines vision for Systems-based Pharmaceutics

NanoString commences second clinical study of PAM50-based breast cancer assay

NeuroSigma Subsidiary sees potential for Thin-Film Nitinol in next-generation flow-diverting stents for treating intracranial aneurysms

Hitting the target: IntelliCap provides reliable and accurate regional drug delivery

Social networks influence beliefs regarding safety of influenza vaccines

Better understanding of new T-size descriptors on adjuvant chemotherapy effect needed

Colonic tissue may help predict Parkinson's disease

Ultrasensitive biosensor may open up new opportunities for early detection of cancer

Mayo Clinic creates comprehensive mobile health application

VATS plays a valuable role in lung cancer screening program

Comcast, UnitedHealth Group completes enrollment in VOD study for type 2 diabetes

Sorin receives PMDA authorization to market MEMO 3D ring

Biomarker test can accurately detect early arthritis symptoms

Avita commences enrollment in ReCell study for hypertrophic dyspigmented scars

HyperBranch’s Adherus AutoSpray Dural Sealant receives CE Marking

Thermo Fisher signs asset purchase agreement with Nephromics for PlGF assay

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News